With a market capitalization (market cap) of $1.66B — a measure of how much the company is worth — Inspire Medical Systems, Inc. is the 2234th most valuable company in Healthcare as of August 18, 2026. Shares trade at $57.38, up +0.28% on the day.
of 2,587
price ÷ annual EPS
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
Visit websiteAs of August 18, 2026, Inspire Medical Systems, Inc. (INSP) is worth $1.66B — this is its market capitalization, the total value of all its outstanding shares.
Inspire Medical Systems, Inc.’s market cap is $1.66B, which ranks it #2234 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
Inspire Medical Systems, Inc. (INSP) shares trade at $57.38, up 0.28% on the day, as of August 18, 2026.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2025
Inspire Medical Systems, Inc. trades at a price-to-earnings (P/E) ratio of 11.6, based on its latest share price and annual earnings per share.